TrialBritish journal of haematology2020

Efficacy and safety of humanized anti-CD19-CAR-T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia.

Jia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.